Journal: Glomerular Diseases
Submission Deadline: August 31, 2026
Medication approaches for the treatment of cancers sometimes cause acute and/or chronic kidney injury. Most often, tubules are the target of this injury, and rare glomerular complications of chimeric antigen receptor T-cell therapy have been reported. In addition, monoclonal antibody therapy and more traditional chemotherapeutic agents have also been reported to cause glomerular inflammation and injury.
Glomerular Diseases seeks original research articles, review articles, case reports, and case series describing the glomerular complications of cancer treatments, and approaches to treatment.
Please select the option “Call for Papers: Glomerular Complications of CAR-T and Cancer Chemotherapies” when submitting your manuscript and mention this Call for Papers in your cover letter.
Article publication is subject to rigorous peer review in line with the journal's editorial policies. Please refer to our author guidelines for further details about the publication conditions.
Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.